In cancer cells, Nrf2 suppresses tumor promotion or conversely exerts pro-tumorigenic effects [60]; however, the Nrf2 signaling pathway in M2-MACs prevents cancer immunosurveillance by producing pro-tumorigenic cytokines. The gene discussed is NFE2L2; the disease is cancer.